Collectively, these findings underscore the cGAS-STING signaling pathway as a critical regulator of immune-inflammatory responses in DCM, emphasizing its potential as a therapeutic target for alleviating complications associated with diabetes. Here, STING1 is linked to familial dilated cardiomyopathy.